Skip to content

Ardelyx ARDX Free cash flow

Free cash flow at other companies

Amgen logo
AmgenAMGN
$1.48B+50.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$121M+26.0%
AbbVie logo
AbbVieABBV
$3.56B+155%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
-$37.9M+43.3%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$119.69M-6.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%

Valuation

See full
Market cap$1.53B+25.5%

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's free cash flow?
Ardelyx (ARDX) reported free cash flow of -$32.31M in Q1 2026.
How has Ardelyx's free cash flow changed year-over-year?
Ardelyx's free cash flow increased by 16.7% year-over-year, from -$38.78M to -$32.31M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.